{"id":"vancomycin-antibiotic-powder","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"null","effect":"Anaphylaxis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Vancomycin is a glycopeptide antibiotic that binds to the D-alanyl-D-alanine terminus of cell wall precursors, preventing the incorporation of these precursors into the bacterial cell wall. This inhibition of cell wall synthesis ultimately leads to cell lysis and death.","oneSentence":"Vancomycin works by inhibiting cell wall synthesis in bacteria, ultimately leading to cell lysis and death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:55:25.043Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of serious or severe bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA)"}]},"trialDetails":[{"nctId":"NCT05421741","phase":"PHASE4","title":"Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2023-05-15","conditions":"Osteomyelitis Tibia, Tibial Fractures, Open Tibia Fracture","enrollment":484},{"nctId":"NCT05615844","phase":"PHASE3","title":"Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2023-11-05","conditions":"Open tíbia Fracture","enrollment":312},{"nctId":"NCT04872400","phase":"PHASE4","title":"Acute Application of Antibiotic Powder in Open Fracture Wounds","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-06-14","conditions":"Fractures, Open, Wounds and Injuries--Infections, Anti-Bacterial Agents","enrollment":20},{"nctId":"NCT04597008","phase":"PHASE3","title":"Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2021-05-11","conditions":"Post Operative Surgical Site Infection","enrollment":1550},{"nctId":"NCT04075526","phase":"PHASE1","title":"Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2019-10-01","conditions":"Osteoarthritis","enrollment":2129},{"nctId":"NCT05766670","phase":"PHASE3","title":"Intramedullary Calcium Sulfate Antibiotic Depot","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-04-08","conditions":"Open tíbia Fracture, Osteomyelitis Tibia, Tibial Fractures","enrollment":497},{"nctId":"NCT06126731","phase":"PHASE1, PHASE2","title":"Combination Study of Antibiotics With Enzalutamide (PROMIZE)","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2023-11-02","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":39},{"nctId":"NCT02284126","phase":"PHASE3","title":"Topical Vancomycin for Neurosurgery Wound Prophylaxis","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-10","conditions":"Infection, Surgery, Nervous System Diseases","enrollment":1103},{"nctId":"NCT03935828","phase":"PHASE2","title":"Effect of Topical Sinonasal Antibiotics","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, San Diego","startDate":"2019-06","conditions":"Chronic Rhinosinusitis (Diagnosis), Antibiotic Side Effect","enrollment":""},{"nctId":"NCT03765567","phase":"PHASE4","title":"Placement of Antibiotic Powder in Wounds During the Emergency Room","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2020-10-05","conditions":"Open Fracture","enrollment":200},{"nctId":"NCT05169229","phase":"PHASE2, PHASE3","title":"Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.","status":"RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2022-04-01","conditions":"Arthroplasty, Replacement, Hip, Osteoarthritis, Hip, Antibiotic Resistant Infection","enrollment":1100},{"nctId":"NCT04017468","phase":"PHASE2","title":"Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2019-10-15","conditions":"Surgical Site Infection","enrollment":450},{"nctId":"NCT05084378","phase":"PHASE3","title":"Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2022-03-11","conditions":"Periprosthetic Joint Infection, Draining Wound","enrollment":495},{"nctId":"NCT05835206","phase":"PHASE2","title":"Further MT for Antibiotic-Resistant Bacterial Colonization in Inpatients","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-04-25","conditions":"Multi-drug Resistant Organism","enrollment":40},{"nctId":"NCT05141903","phase":"","title":"Dietary Supplement With and Without a Probiotic and/or Antibiotic","status":"COMPLETED","sponsor":"Prolacta Bioscience","startDate":"2021-09-21","conditions":"Healthy Adults","enrollment":92},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":"Infections","enrollment":10},{"nctId":"NCT03839914","phase":"NA","title":"Evaluating the Efficacy and Safety of Intra-wound Vancomycin Powder in High Risk Patients","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2020-08-01","conditions":"Spinal Deformity, Trauma, Spinal Tumor","enrollment":76},{"nctId":"NCT04993027","phase":"PHASE2","title":"Topical Vancomycin for Infection Prophylaxis in TJA","status":"NOT_YET_RECRUITING","sponsor":"Alberta Hip and Knee Clinic","startDate":"2025-12-30","conditions":"Infection of Total Hip Joint Prosthesis, Infection of Total Knee Joint Prosthesis","enrollment":100},{"nctId":"NCT05363462","phase":"NA","title":"Topical Antibiotics in Surgical Site","status":"COMPLETED","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2022-01-05","conditions":"Surgical Site Infection, Complication of Surgical Procedure","enrollment":75},{"nctId":"NCT05625373","phase":"PHASE2, PHASE3","title":"The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2022-10-25","conditions":"Postoperative Complications","enrollment":30},{"nctId":"NCT05461651","phase":"NA","title":"Infection Prevention After TKA With or Without Vancomycin","status":"RECRUITING","sponsor":"Centre of Postgraduate Medical Education","startDate":"2021-09-01","conditions":"Infection","enrollment":1800},{"nctId":"NCT04297631","phase":"PHASE4","title":"Intraarticular Antibiotic in TKA","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-02-14","conditions":"Antibotics in Cementless Knees","enrollment":20},{"nctId":"NCT02227446","phase":"PHASE3","title":"Local Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: A Multicenter Randomized, Controlled Trial (VANCO)","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2014-10","conditions":"Post Operative Surgical Site Infection","enrollment":1036},{"nctId":"NCT02631408","phase":"PHASE4","title":"Intrawound Vancomycin Powder in Spinal Fusion Surgery","status":"COMPLETED","sponsor":"Orthopedic Hospital Vienna Speising","startDate":"2015-08","conditions":"Spinal Fusion Acquired","enrollment":308},{"nctId":"NCT03928522","phase":"PHASE4","title":"Antibiotic Elution in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-28","conditions":"Total Knee Replacement","enrollment":60},{"nctId":"NCT03157388","phase":"NA","title":"The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2017-06-01","conditions":"Alcoholic Hepatitis","enrollment":15},{"nctId":"NCT02968693","phase":"","title":"Drug Delivery Devices for Osteomyelitis","status":"COMPLETED","sponsor":"Yulin Orthopedics Hospital of Chinese and Western Medicine","startDate":"2011-04","conditions":"Osteomyelitis","enrollment":51},{"nctId":"NCT01764750","phase":"PHASE1","title":"Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2013-01","conditions":"Surgical Site Infection","enrollment":10},{"nctId":"NCT01633762","phase":"EARLY_PHASE1","title":"Eradication of Gut Microbiota","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2012-04","conditions":"Diabetes, Obesity, Osteoporosis","enrollment":12},{"nctId":"NCT02299882","phase":"NA","title":"Surgical Infection Rates With Adjunct Vancomycin Compared to Standard Peri-Operative IV Antibiotics","status":"UNKNOWN","sponsor":"Corewell Health West","startDate":"2012-08","conditions":"Lumbar Pain","enrollment":700},{"nctId":"NCT01372371","phase":"NA","title":"Efficacy of Local Powder Prophylactics","status":"UNKNOWN","sponsor":"Ganga Hospital","startDate":"2011-06","conditions":"Infection","enrollment":1844}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":31,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vancomycin antibiotic powder","genericName":"Vancomycin antibiotic powder","companyName":"Major Extremity Trauma Research Consortium","companyId":"major-extremity-trauma-research-consortium","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Vancomycin antibiotic powder is used to prevent infections such as Ventriculoperitoneal Shunt Infection, Surgical Site Infection, and Cerebrospinal Fluid Shunt Infection, particularly in pediatric patients. The exact mechanism of action of Vancomycin powder is unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}